hydroxychloroquine has been researched along with Angioedema in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Angioedema: Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hydroxychloroquine therapy induced simultaneous resolution of lupus and angioedema." | 3.68 | Acquired C1 inhibitor deficiency revealing systemic lupus erythematosus. ( Bagot, M; Intrator, L; Ochonisky, S; Revuz, J; Wechsler, J, 1993) |
| "The patient was diagnosed with systemic lupus erythematosus with the presence of polyarthralgia, angioedema, leucopenia, and positivity of immunologic criteria." | 2.58 | Acquired angioedema in juvenile systemic lupus erythematosus: case-based review. ( Tekin, ZE; Yener, GO; Yüksel, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Azmy, V | 1 |
| Benson, J | 1 |
| Love, K | 1 |
| Steele, R | 1 |
| Tekin, ZE | 1 |
| Yener, GO | 1 |
| Yüksel, S | 1 |
| Vincent, D | 1 |
| Ponard, D | 1 |
| Fiorella, S | 1 |
| Drouet, C | 1 |
| Palazzi, C | 1 |
| D'Amico, E | 1 |
| Cacciatore, P | 1 |
| Pennese, E | 1 |
| Olivieri, I | 1 |
| Ko, CH | 1 |
| Ng, J | 1 |
| Kumar, S | 1 |
| Hurst, M | 1 |
| Ochonisky, S | 1 |
| Intrator, L | 1 |
| Wechsler, J | 1 |
| Revuz, J | 1 |
| Bagot, M | 1 |
2 reviews available for hydroxychloroquine and Angioedema
| Article | Year |
|---|---|
Acquired angioedema in juvenile systemic lupus erythematosus: case-based review.
Topics: Adolescent; Angioedema; Complement C1 Inactivator Proteins; Female; Humans; Hydroxychloroquine; Lupu | 2018 |
Life-threatening angioedema in a patient with systemic lupus.
Topics: Administration, Oral; Adult; Airway Obstruction; Analgesics; Angioedema; Dose-Response Relationship, | 2006 |
4 other studies available for hydroxychloroquine and Angioedema
| Article | Year |
|---|---|
Idiopathic nonhistaminergic acquired angioedema in a patient with coronavirus disease 2019.
Topics: Adenosine Monophosphate; Adult; Alanine; Ampicillin; Angioedema; Betacoronavirus; Coronavirus Infect | 2020 |
Benefits of hydroxychloroquine in the treatment of a patient with angioedema due to acquired C1 inhibitor deficiency.
Topics: Aged; Angioedema; Angioedemas, Hereditary; Antibodies, Blocking; Autoantibodies; Autoimmunity; Compl | 2015 |
Non-rheumatoid erosive arthritis associated with type I hereditary angioedema.
Topics: Angioedema; Antirheumatic Agents; Arthritis; Arthroplasty, Replacement, Hip; Female; Hip Joint; Huma | 2005 |
Acquired C1 inhibitor deficiency revealing systemic lupus erythematosus.
Topics: Angioedema; Complement C1 Inactivator Proteins; Female; Humans; Hydroxychloroquine; Immunologic Defi | 1993 |